Royal Bank of Canada’s Forte Biosciences FBRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $119K | Buy |
9,234
+5,892
| +176% | +$75.9K | ﹤0.01% | 5184 |
|
2025
Q1 | $26K | Sell |
3,342
-442
| -12% | -$3.44K | ﹤0.01% | 5441 |
|
2024
Q4 | $86K | Buy |
+3,784
| New | +$86K | ﹤0.01% | 4956 |
|
2024
Q3 | – | Sell |
-5
| Closed | – | – | 6522 |
|
2024
Q2 | $0 | Hold |
5
| – | – | ﹤0.01% | 6748 |
|
2024
Q1 | $0 | Buy |
+5
| New | – | ﹤0.01% | 6645 |
|
2023
Q3 | – | Sell |
-6
| Closed | – | – | 6678 |
|
2023
Q2 | $0 | Sell |
6
-1
| -14% | – | ﹤0.01% | 6873 |
|
2023
Q1 | $0 | Hold |
7
| – | – | ﹤0.01% | 6725 |
|
2022
Q4 | $0 | Sell |
7
-2
| -22% | – | ﹤0.01% | 6853 |
|
2022
Q3 | $0 | Buy |
9
+2
| +29% | – | ﹤0.01% | 7033 |
|
2022
Q2 | $0 | Sell |
7
-46
| -87% | – | ﹤0.01% | 6956 |
|
2022
Q1 | $2K | Sell |
53
-69
| -57% | -$2.6K | ﹤0.01% | 6986 |
|
2021
Q4 | $7K | Buy |
122
+76
| +165% | +$4.36K | ﹤0.01% | 6609 |
|
2021
Q3 | $4K | Buy |
46
+15
| +48% | +$1.3K | ﹤0.01% | 6665 |
|
2021
Q2 | $26K | Buy |
+31
| New | +$26K | ﹤0.01% | 5920 |
|
2020
Q4 | – | Sell |
-1
| Closed | -$1K | – | 6544 |
|
2020
Q3 | $1K | Sell |
1
-2
| -67% | -$2K | ﹤0.01% | 5922 |
|
2020
Q2 | $1K | Sell |
3
-15
| -83% | -$5K | ﹤0.01% | 5935 |
|
2020
Q1 | $8K | Buy |
+18
| New | +$8K | ﹤0.01% | 5395 |
|
2018
Q4 | – | Sell |
-1
| Closed | -$5K | – | 5895 |
|
2018
Q3 | $5K | Buy |
+1
| New | +$5K | ﹤0.01% | 5642 |
|
2018
Q2 | – | Hold |
0
| – | – | – | 5763 |
|
2018
Q1 | – | Sell |
-83
| Closed | -$320K | – | 5777 |
|
2017
Q4 | $320K | Buy |
83
+81
| +4,050% | +$312K | ﹤0.01% | 3451 |
|
2017
Q3 | $7K | Buy |
+2
| New | +$7K | ﹤0.01% | 5593 |
|
2017
Q2 | – | Hold |
0
| – | – | – | 5828 |
|